Tat-NR2B9c TFA
|
T650460-5mg
|
≥99% |
1834571-04-8 |
5mg
|
¥ 1800.9
|
期货,请咨询 |
阿拉丁 |
Tat-NR2B9c TFA
|
T650460-25mg
|
≥99% |
1834571-04-8 |
25mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
Tat-NR2B9c TFA
|
T650460-1mg
|
≥99% |
1834571-04-8 |
1mg
|
¥ 700.9
|
期货,请咨询 |
阿拉丁 |
Tat-NR2B9c TFA
|
T650460-10mg
|
≥99% |
1834571-04-8 |
10mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
Tecastemizole
|
T650436-5mg
|
≥99% |
75970-99-9 |
5mg
|
¥ 2600.9
|
期货,请咨询 |
阿拉丁 |
Tecastemizole
|
T650436-50mg
|
≥99% |
75970-99-9 |
50mg
|
¥ 12800.9
|
期货,请咨询 |
阿拉丁 |
Tecastemizole
|
T650436-25mg
|
≥99% |
75970-99-9 |
25mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
Tecastemizole
|
T650436-10mg
|
≥99% |
75970-99-9 |
10mg
|
¥ 3800.9
|
期货,请咨询 |
阿拉丁 |
(1R)-Tenofovir amibufenamide
|
T650412-5mg
|
|
1571076-15-7 |
5mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
(1R)-Tenofovir amibufenamide
|
T650412-10mg
|
|
1571076-15-7 |
10mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
Taltobulin trifluoroacetate
|
T650359-5mg
|
≥99% |
228266-41-9 |
5mg
|
¥ 2750.9
|
期货,请咨询 |
阿拉丁 |
Taltobulin trifluoroacetate
|
T650359-10mg
|
≥99% |
228266-41-9 |
10mg
|
¥ 4100.9
|
期货,请咨询 |
阿拉丁 |
TP-10
|
T650352-5mg
|
≥99% |
898563-00-3 |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
TP-10
|
T650352-50mg
|
≥99% |
898563-00-3 |
50mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
TP-10
|
T650352-10mg
|
≥99% |
898563-00-3 |
10mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
TP-10
|
T650352-100mg
|
≥99% |
898563-00-3 |
100mg
|
¥ 21000.9
|
期货,请咨询 |
阿拉丁 |
TPOP146
|
T650326-5mg
|
≥98% |
2018300-62-2 |
5mg
|
¥ 1050.9
|
期货,请咨询 |
阿拉丁 |
TPOP146
|
T650326-50mg
|
≥98% |
2018300-62-2 |
50mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
TPOP146
|
T650326-10mg
|
≥98% |
2018300-62-2 |
10mg
|
¥ 1800.9
|
期货,请咨询 |
阿拉丁 |
TPOP146
|
T650326-100mg
|
≥98% |
2018300-62-2 |
100mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
TLR8 agonist 5
|
T650313-5mg
|
≥96% |
2413016-41-6 |
5mg
|
¥ 3400.9
|
期货,请咨询 |
阿拉丁 |
TLR8 agonist 5
|
T650313-25mg
|
≥96% |
2413016-41-6 |
25mg
|
¥ 10350.9
|
期货,请咨询 |
阿拉丁 |
TLR8 agonist 5
|
T650313-10mg
|
≥96% |
2413016-41-6 |
10mg
|
¥ 5400.9
|
期货,请咨询 |
阿拉丁 |
Tarlatamab
|
T650307-1mg
|
|
2307488-83-9 |
1mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |